Ga naar inhoud

ONCOgenic GPCR Network of Excellence and Training

Marie Skłodowska-Curie Action
Innovative Training Networks (ITN)
2020-2024

Follow us on:

Marie Skłodowska-Curie Action
Innovative Training Networks (ITN)
2020-2024

Follow us on:

ONCOgenic GPCR Network of Excellence and Training

  • Home
  • People
    • Beneficiaries (2020-2024)
    • Early Stage Researchers (ESR) (2020-2024)
    • Partner Organizations (2020-2024)
  • Training
  • Projects
  • Recruitment
  • Newsfeed
  • Dissemination
  • Alumni
  • Contact
  • Oncornet 1.0
    • About
    • People
    • Beneficiaries
    • Early Stage Researchers (ESR)
    • Partner Organizations (2015-2019)
    • Training (2015-2019)
    • Projects
    • Recruitment
    • Newsfeed
    • Dissemination
    • Alumni
    • Contact
Menu Sluiten
  • Home
  • People
    • Beneficiaries (2020-2024)
    • Early Stage Researchers (ESR) (2020-2024)
    • Partner Organizations (2020-2024)
  • Training
  • Projects
  • Recruitment
  • Newsfeed
  • Dissemination
  • Alumni
  • Contact
  • Oncornet 1.0
    • About
    • People
    • Beneficiaries
    • Early Stage Researchers (ESR)
    • Partner Organizations (2015-2019)
    • Training (2015-2019)
    • Projects
    • Recruitment
    • Newsfeed
    • Dissemination
    • Alumni
    • Contact

  • Home
  • People
    • Beneficiaries (2020-2024)
    • Early Stage Researchers (ESR) (2020-2024)
    • Partner Organizations (2020-2024)
  • Training
  • Projects
  • Recruitment
  • Newsfeed
  • Dissemination
  • Alumni
  • Contact
  • Oncornet 1.0
    • About
    • People
    • Beneficiaries
    • Early Stage Researchers (ESR)
    • Partner Organizations (2015-2019)
    • Training (2015-2019)
    • Projects
    • Recruitment
    • Newsfeed
    • Dissemination
    • Alumni
    • Contact

Projects (2015-2019)

1. Small ligands to modulate CXCR4 and CXCR7 mono-, homo-, and heteromers

2. Pepducins to modulate CXCR4 and CXCR7 mono-, homo-, and heteromers

3. Nanobodies/antibodies to modulate and detect CXCR4 and CXCR7 mono-, homo-, and heteromers  

4. Development of CXCR4 and CXCR7 specific chemokines and reagents 

5. In silico guided identification of molecular determinants for modulation of CXCR4 and CXCR7

6. Functional properties of CXCR4 and CXCR7 homo- and heteromers

7. G protein-dependent signalling by CXCR4 and CXCR7

8. Role of G protein-coupled receptor kinases (GRKs) in CXCR4 and CXCR7 signalling and modulation 

9. Analysis of biased signalling responses through CXCR4 and CXCR7 

10. Differential phosphorylation of CXCR4 and CXCR7 

11. Localization and trafficking of CXCR4 and CXCR7 

12. Functional proteomics of CXCR4 and CXCR7-associated signalling networks 

13. Development of (patho)physiological in vitro and in vivo models to assess effect of CXCR4/CXCR7 modulators

14. Genetic mouse models and in vivo studies

15. In situ analysis of CXCR4 and CXCR7 ligand-binding and spatio-temporal localization using imaging tools on ex vivo samples

All positions are filled

Contact details

Please contact us at:
info@oncornet.eu

ONCORNET Coordinator
VU University Amsterdam
The Netherlands

Funded by

Marie Curie Actions

EU Horizon 2020

European Union


Privacystatement | Website by MaliCompany © | All rights reserved